SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001214659-15-006131
Filing Date
2015-08-17
Accepted
2015-08-17 16:34:37
Documents
3
Period of Report
2015-08-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 l8131518k.htm 8-K 36830
2 EXHIBIT 5.1 ex5_1.htm EX-5.1 12683
3 logo.jpg GRAPHIC 7721
  Complete submission text file 0001214659-15-006131.txt   61374
Mailing Address 25801 INDUSTRIAL BOULEVARD, SUITE B HAYWARD CA 94545
Business Address 25801 INDUSTRIAL BOULEVARD, SUITE B HAYWARD CA 94545 (510) 856-5600
Anthera Pharmaceuticals Inc (Filer) CIK: 0001316175 (see all company filings)

IRS No.: 201852016 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34637 | Film No.: 151059286
SIC: 2834 Pharmaceutical Preparations